raltegravir
Interviews and expert commentary tagged “raltegravir” — the latest oncology research and clinical practice from the Audio Journal of Oncology.
Audio Journal of Oncology
Integrase Inhibitor Raltegravir Doubles Antiviral Response Rate in Treatment Experienced HIV-Infected Patients Compared to Optimised Background Therapy Alone
ROY STEIGBIGEL, State University of New York at Stony Brook JOHN W. MELLORS, University of Pittsburgh REFERENCE: Abstract 105aLB, 105bLB, 14th Conference on Retroviruses and Opportunistic Infections,
6 March 2007
0:00